Muscle Loss on GLP-1 Medications: What the Research Says and What You Can Do

One of the most important things to understand when starting a GLP-1 medication like semaglutide or tirzepatide is muscle loss: what causes it, why it matters, and what you can do about it.

Muscle supports your strength, energy, blood sugar regulation, and ability to move through daily life. These medications can reduce appetite significantly. When overall food intake drops and protein intake falls alongside it, the body can begin breaking down muscle tissue for energy. That makes preserving muscle during treatment worth real attention.

What the Research Shows

As the body changes during treatment, the loss is a mix of body fat and muscle, not body fat alone. Body composition data from the STEP trials on semaglutide and the SURMOUNT trials on tirzepatide both reflect this.*

How much muscle someone loses varies from person to person and depends on the medication. But the overall pattern is clear. In studies of both semaglutide and tirzepatide, most of the weight people lost was body fat. The amount that came from muscle varied, but it was enough to matter.

This is not unique to GLP-1 medications. Any significant reduction in food intake, regardless of the cause, carries some risk of lean mass loss. What makes GLP-1 medications notable is the degree of appetite suppression, which can make it genuinely difficult to eat enough protein to support muscle. The focus here is on protecting the muscle that supports your strength, energy, and function.

Why Muscle Mass Matters

Muscle is metabolically active tissue. It plays a direct role in blood sugar regulation, energy expenditure, and physical function, and it is where most of the glucose from your meals is taken up. That makes it relevant not only to how you move and feel, but to how your body manages blood sugar over time.

For older adults, this matters even more. Sarcopenia, the age-related loss of muscle mass, is associated with increased risk of falls, functional decline, and reduced quality of life. GLP-1 medications used in midlife or later call for especially deliberate attention to protein intake and resistance training.

The Role of Protein

Adequate protein intake is the most evidence-based nutritional strategy for muscle preservation during periods of reduced food intake. Protein needs go up when overall intake drops, and the right target depends on your age, activity, and medical history, which is one reason individualized guidance is valuable.

The challenge on a GLP-1 medication is that appetite suppression makes eating enough protein genuinely difficult. With appetite reduced, hunger may not prompt you to eat enough protein, so meeting your targets takes some intentional planning.

Distributing protein across the day supports muscle protein synthesis and is often more practical than concentrating it in one or two meals, particularly when appetite is suppressed and large meals feel difficult.

Easy, protein-rich options tend to help most when appetite is low: Greek yogurt, eggs, cottage cheese, fish, poultry, tofu, beans and lentils, milk, and protein smoothies when solid food feels like too much.

The full GLP-1 Packet walks through specific protein recommendations and how to translate them into meals, and meeting with a registered dietitian can tailor those numbers to you.

The Role of Resistance Training

Protein alone is not enough. Resistance training, any movement that asks muscles to work against a load, sends a direct signal to the body to preserve and build muscle tissue, even when food intake is reduced.

Research consistently shows that strength training while eating less helps you hold on to more muscle than you would without it. Pairing that training with enough protein works better than doing either one on its own.

Resistance training does not require a gym or heavy equipment. Bodyweight exercises, resistance bands, and functional movements like squats and lunges all qualify. General physical activity guidelines suggest working all the major muscle groups on two or more days a week. Increasing the challenge over time can be as simple as adding a few more repetitions, using a heavier band, or adding a set as a movement starts to feel easier. If you are newer to strength training, a movement professional can help you build a plan that fits you.

What This Means in Practice

Muscle loss tends to track with the period of active weight change, so this attention matters most while the medication is having its strongest effect on appetite. Protecting muscle on a GLP-1 medication is not complicated, but it does take intention. Including protein where you can, spreading it across the day, and incorporating some form of resistance training consistently are the three most evidence-supported strategies.

For personalized guidance on what this looks like for your body, your activity level, and your current eating patterns, working with a registered dietitian is the most effective starting point.

The complete picture of nutrition on semaglutide and tirzepatide, including protein needs, meal ideas, and what to expect month by month, is covered in depth in the Wilfong Nutrition GLP-1 Packet.

If you are in Texas and looking for individualized GLP-1 nutrition support, we work with clients via telehealth across the state and in person in Austin.

Get in touch with our team to ask about availability and insurance coverage.

*References

In the STEP 1 body composition substudy, semaglutide 2.4 mg over 68 weeks reduced body weight by about 15 percent, total fat mass by about 19 percent, and total lean mass by about 10 percent, with lean mass rising as a proportion of total body mass. Wilding JP, Batterham RL, Calanna S, et al. Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the STEP 1 study. Journal of the Endocrine Society. 2021;5(Suppl 1):A16-A17.

In the SURMOUNT 1 body composition substudy, tirzepatide over 72 weeks reduced body weight by about 21 percent, with roughly 75 percent of the weight lost from fat mass and 25 percent from lean mass. Look M, Dunn JP, Kushner RF, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes, Obesity and Metabolism. 2025;27(5):2720-2729.